Note 2 - Reconciliation of Net Surplus to Net Cash Flows from Operating Activities
| 2010/11 | 2011/12 | 2012/13 | ||
|---|---|---|---|---|
| Actual $000 | In 2011 Budget $000 | Estimated Actual $000 | Budgeted $000 | |
Net surplus/(deficit) | 52,482 | - | 17,294 | - |
| Depreciation and amortisation | 122,277 | 134,344 | 145,333 | 138,512 |
| Increase/(decrease) in non-current employee entitlements | (304) | - | - | |
| Biological assets revaluation gain | (8,405) | |||
| Increase/(decrease) in non-cash items | - | - | - | |
Total non-cash items | 113,568 | 134,344 | 145,333 | 138,512 |
| Increase/(decrease) in receivables | (42,492) | - | (24,597) | 2,491 |
| Increase/(decrease) in inventory | 4,449 | - | (760) | - |
| Increase/(decrease) in prepayment | 589 | - | (1,233) | - |
| Increase/(decrease) in creditors and payables | 11,619 | 213 | (6,518) | 99 |
| Increase/(decrease) in provisions | (3,505) | 4 | - | |
| Increase/(decrease) in current employee entitlements | (189) | - | - | - |
Working capital movements - net | (29,529) | 213 | (33,104) | 2,590 |
| Dividends | - | - | - | - |
| Biological assets revaluation loss | 189 | - | - | - |
| Investments revaluation loss | - | - | - | - |
| Net loss/(gain) on sale or disposal of physical assets | 19,333 | - | - | - |
| Net loss/(gain) on sale or disposal of investments | - | - | - | - |
Total investing activities | 19,522 | - | - | - |
Net cash flow from operating activities | 156,043 | 134,557 | 129,523 | 141,102 |
